.png){kind=logo}
GeneDx Holdings Corp. operates as a top genomics firm which uses advanced whole exome and genome sequencing methods to diagnose rare diseases and pediatric disorders. The company uses its GeneDx Infinity dataset together with AI-driven insights to provide accurate genetic testing and speed up drug development while working to establish genomic medicine as an international standard treatment.
GeneDx Holdings Corp. operates as a health intelligence organization which provides advanced genetic testing services and data-based insights for precision medicine applications. The company uses its genomic analysis services and AI interpretation platforms to transform intricate genetic data into precise clinical recommendations.
The company provides support to clinicians, healthcare institutes and biopharma organizations in their work with inherited disorders, oncology, cardiology and metabolic conditions. The company uses its extensive scientific knowledge and its strong rare disease data resources to improve diagnostic methods and develop personalized treatment solutions and advance medical research efforts.
GeneDx offers genetic testing products like GenomeDx and ExomeDx, along with rapid and ultra-rapid sequencing and targeted variant testing. Their AI-powered interpretation and GeneDx Infinity dataset enable accurate diagnoses for rare diseases, pediatric conditions, and complex genetic disorders, supporting clinical care and research.
GeneDx generates its income through advanced genetic testing services which provide both testing and result assessment, while the company expands its testing capabilities through new clinical applications, its artificial intelligence insights, its testing coverage and its acquisition strategy, which together create a reliable stream of financial growth.
Client Segments: Hospitals, health systems, clinics, diagnostic labs, biopharma companies, research institutions, genetic counseling centers.
Target Companies: Healthcare providers, pediatric and rare disease specialty clinics, academic medical centers, pharmaceutical and biotech firms, clinical research organizations.
Target Geography: United States, North America, and global markets via partnerships and clinical networks.
Client Segments: Clinicians, genetic counselors, healthcare providers who order tests for patients.
Target Companies: Health systems and physician networks delivering genomic testing services.
Target Geography: United States and international markets with genomic testing services through healthcare networks.
